REPORTS

Let’s Pullulate and Expand Your Business

Glutamate Receptor Ionotropic NMDA 2B Market - Global Professional Analysis and Forecast to 2026

Feb 10, 2020  |  159 PAGES  |  REPORT CODE: CMM266059
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Glutamate Receptor Ionotropic NMDA 2B market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.1% during the forecast period.

This report presents the market size and development trends by detailing the Glutamate Receptor Ionotropic NMDA 2B market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Glutamate Receptor Ionotropic NMDA 2B market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Glutamate Receptor Ionotropic NMDA 2B industry and will help you to build a panoramic view of the industrial development.

Glutamate Receptor Ionotropic NMDA 2B Market, By Type:

  • JNJ-0808

  • Neu-2000

  • NP-10679

  • NP-11948

  • Radiprodil

  • Others

Glutamate Receptor Ionotropic NMDA 2B Market, By Application:

  • Acute Ischemic Stroke

  • Autism

  • Brasin Ischemia

  • Burns

  • Others

Some of the leading players are as follows:

  • Bristol-Myers Squibb Company

  • Novartis AG

  • Johnson & Johnson

  • BioCrea GmbH

  • NeurOp, Inc

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Glutamate Receptor Ionotropic NMDA 2B Market: Technology Type Analysis

  • 4.1 Glutamate Receptor Ionotropic NMDA 2B Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Glutamate Receptor Ionotropic NMDA 2B Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 JNJ-0808

    • 4.3.2 Neu-2000

    • 4.3.3 NP-10679

    • 4.3.4 NP-11948

    • 4.3.5 Radiprodil

    • 4.3.6 Others

5 Glutamate Receptor Ionotropic NMDA 2B Market: Product Analysis

  • 5.1 Glutamate Receptor Ionotropic NMDA 2B Product Market Share Analysis, 2018 & 2026

  • 5.2 Glutamate Receptor Ionotropic NMDA 2B Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Glutamate Receptor Ionotropic NMDA 2B Market: Application Analysis

  • 6.1 Glutamate Receptor Ionotropic NMDA 2B Application Market Share Analysis, 2018 & 2026

  • 6.2 Glutamate Receptor Ionotropic NMDA 2B Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Acute Ischemic Stroke

    • 6.3.2 Autism

    • 6.3.3 Brasin Ischemia

    • 6.3.4 Burns

    • 6.3.5 Others

7 Glutamate Receptor Ionotropic NMDA 2B Market: Regional Analysis

  • 7.1 Glutamate Receptor Ionotropic NMDA 2B Regional Market Share Analysis, 2018 & 2026

  • 7.2 Glutamate Receptor Ionotropic NMDA 2B Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Bristol-Myers Squibb Company

    • 9.1.1 Bristol-Myers Squibb Company Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Novartis AG

    • 9.2.1 Novartis AG Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Johnson & Johnson

    • 9.3.1 Johnson & Johnson Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 BioCrea GmbH

    • 9.4.1 BioCrea GmbH Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 NeurOp, Inc

    • 9.5.1 NeurOp, Inc Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

 

The List of Tables and Figures (Totals 79 Figures and 134 Tables)

  • Figure JNJ-0808 Glutamate Receptor Ionotropic NMDA 2B market, 2015 - 2026 (USD Million)

  • Figure Neu-2000 Glutamate Receptor Ionotropic NMDA 2B market, 2015 - 2026 (USD Million)

  • Figure NP-10679 Glutamate Receptor Ionotropic NMDA 2B market, 2015 - 2026 (USD Million)

  • Figure NP-11948 Glutamate Receptor Ionotropic NMDA 2B market, 2015 - 2026 (USD Million)

  • Figure Radiprodil Glutamate Receptor Ionotropic NMDA 2B market, 2015 - 2026 (USD Million)

  • Figure Others Glutamate Receptor Ionotropic NMDA 2B market, 2015 - 2026 (USD Million)

  • Figure Acute Ischemic Stroke market, 2015 - 2026 (USD Million)

  • Figure Autism market, 2015 - 2026 (USD Million)

  • Figure Brasin Ischemia market, 2015 - 2026 (USD Million)

  • Figure Burns market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Glutamate Receptor Ionotropic NMDA 2B market, by country, 2015 - 2026 (USD Million)

  • Table North America Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table North America Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table North America Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table Canada Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table Canada Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Europe Glutamate Receptor Ionotropic NMDA 2B market, by country, 2015 - 2026 (USD Million)

  • Table Europe Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table Europe Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table Europe Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table Germany Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table Germany Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table France Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table France Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table Italy Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table Italy Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table Spain Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table Spain Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Glutamate Receptor Ionotropic NMDA 2B market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table China Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table China Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table Japan Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table Japan Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table India Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table India Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Glutamate Receptor Ionotropic NMDA 2B market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table MEA Glutamate Receptor Ionotropic NMDA 2B market, by country, 2015 - 2026 (USD Million)

  • Table MEA Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table MEA Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table MEA Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Glutamate Receptor Ionotropic NMDA 2B market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Glutamate Receptor Ionotropic NMDA 2B market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Glutamate Receptor Ionotropic NMDA 2B market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Bristol-Myers Squibb Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BioCrea GmbH Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table NeurOp, Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top